| Literature DB >> 26693003 |
Liliana Kiczak1, Alicja Tomaszek2, Urszula Pasławska3, Jacek Bania4, Agnieszka Noszczyk-Nowak3, Piotr Skrzypczak5, Robert Pasławski6, Maciej Zacharski1, Adrian Janiszewski3, Piotr Kuropka7, Piotr Ponikowski2, Ewa A Jankowska2.
Abstract
BACKGROUND: Although sex differences in heart failure (HF) prevalence and severity have been recognized, its molecular mechanisms are poorly understood. We used a tachycardia-induced cardiomyopathy model to determine the sex specific remodeling pattern in male and female adult pigs.Entities:
Keywords: Experimental model of heart failure; Extracellular matrix turnover; Myocardial remodeling; Sex
Year: 2015 PMID: 26693003 PMCID: PMC4676102 DOI: 10.1186/s13293-015-0048-4
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 5.027
Oligonucleotide primers used in RT-PCR experiments
| Gene | Sequence 5′-3′ | GenBank accession no. |
|---|---|---|
| GAPDH | TCACTGCCACCCAGAAGA | ABO38240 |
| BNP | GATACAGGAGCTGCTGGAC | M23596 |
| GATA4 | CAGCAGCAGCGAAGAGATG | AY115491 |
| TGF-β1 | CTACTACGCCAAGGAGGTCAC | X12373 |
| MMP9 | CCACAGGCCCTCCTTCAG | NM001038004 |
| NGAL | TTAAGAAATACTCTGGATTGC | AK240091 |
| TIMP1 | AGCCAGGAGTTTCTCATAGC | NM213857 |
| Col1A1 | AGCGGAGAATACTGGATTGAC | AF201723 |
| Col1A2 | ATGCCGTGACTTGAGACTC | AB237775 |
| Col3A1 | CGGACAAATAGAAAGCCTCATTAG | DT322297 |
GAPDH glyceraldehyde-3-phosphate dehydrogenase, BNP B-type natriuretic peptide, GATA4 GATA binding protein type 4, TGF-β1 transforming growth factor β1, MMP9 matrix metalloproteinase type 9, NGAL neutrophil gelatinase-associated lipocalin, TIMP1 tissue inhibitor of metalloproteinases type 1, Col1A1 collagen type 1 α1, Col1A2 collagen type I α2, Col3A1 collagen type III α1
Fig. 1Indices of LV function at different time points for sham-operated pigs and RV-paced pigs. a and b show changes over time in left ventricular ejection fraction (LVEF, %); c and d show left ventricular end diastolic volume (LVEDV, ml); e and f show end diastolic relative wall thickness (RWTd, RWTd = 2 × LVPWd/LVIDd, LVIDd left ventrical internal dimension in diastole) in right ventricular (RV) paced and sham-operated pigs; g and h show the ratio of an early and late diastolic velocity (Em/Am) separately in male and female animals (black squares—RV paced female pigs, black circles—RV paced male pigs, gray squares—female controls, gray circles—male controls). Values are presented as means ± SEM. Data (separately for control and TIC animals) were tested using one-way ANOVA
Echocardiography parameters reflecting the structure and functioning of left ventricle in sham-operated male pigs (controls) and right ventricle paced pigs with induced heart failure
| LVEDV, ml | LVEDV, relative increase, % | LVEF, % | LA/Ao | RWTd | Em/Am | |
|---|---|---|---|---|---|---|
| Controls, females | 187.5 ± 35.9 | 115.6 ± 19.7 | 60.1 ± 8.4 | 1.43 ± 0.21 | 0.32 ± 0.04 | 1.42 ± 0.15 |
| Mild HF, females | 197.1 ± 50.5 | 122.9 ± 23.9 | 31.7 ± 12.7* | 2.24 ± 0.34* | 0.32 ± 0.10 | 2.65 ± 1.62 |
| Moderate HF, females | 273.8 ± 66.3* | 122.6 ± 14.9 | 41.2 ± 16.9* | 1.94 ± 0.49* | 0.28 ± 0.04 | 1.91 ± 0.40 |
| Severe HF, females | 276.2 ± 104.8 | 99.5 ± 12.4 | 19.6 ± 6* | 2.32 ± 0.19* | 0.29 ± 0.06 | 2.61 ± 1.68 |
| Controls, males | 192.4 ± 24.0 | 120.5 ± 44.8 | 53.5 ± 8.4 | 1.38 ± 0.18 | 0.35 ± 0.06 | 1.80 ± 0.58 |
| Mild HF, males | 238.9 ± 31.1*& | 148.9 ± 58.6* | 42.4 ± 12.7* | 1.96 ± 0.28 | 0.26 ± 0.05* | 2.24 ± 0.87 |
| Moderate HF, males | 296.7 ± 41.8* | 126.4 ± 62.0 | 28.0 ± 13.4* | 1.98 ± 0.36* | 0.27 ± 0.04* | 2.51 ± 1.41 |
| Severe HF, males | 288.7 ± 34.3*& | 96.0 ± 40.5 | 20.2 ± 6.4* | 2.59 ± 0.28* | 0.28 ± 0.06* | 2.33 ± 0.68 |
HF heart failure, LVEDV left ventricular end-diastolic volume, LVEDV, relative increase relative increase of left ventricular end diastolic volume (LVEDV measured in end-point/LVEDV 1 month before euthanasia)*100 %; LVEF left ventricular ejection fraction, RWTd relative wall thickness at end diastole (2 × LVPWd/LVEDD, LVEDD left ventrical end-diastolic diameter); LA/Ao left atrial/aorta ratio, Em/Am early diastolic to late diastolic velocity ratio. All echocardiography measures were performed directly before a euthanasia. Data are presented as means ± SD
*p < 0.05 vs. control group
&p < 0.05 vs. corresponding female group
Relationships between selected echocardiographic parameters and molecular markers related to myocardial remodelling assessed in left ventricle and HF in male and female pigs with and without tachycardia-induced cardiomyopathy (the results of Spearman’s rank correlation coefficients)
| Variables (units) | Male | Female | ||
|---|---|---|---|---|
|
|
|
|
| |
| LVEF (%) | −0.76 | <0.001 | −0.54 | 0.03 |
| LVEDV (ml) | 0.76 | <0.001 | 0.18 | 0.50 |
| LVEDV, relative increase (%) | −0.42 | 0.04 | −0.2 | 0.47 |
| LA/Ao | 0.78 | <0.001 | 0.62 | 0.009 |
| RWTd | −0.56 | 0.002 | −0.23 | 0.38 |
| Em/Am | 0.20 | 0.35 | −0.07 | 0.78 |
| BNP, mRNA (AU) | 0.74 | <0.001 | 0.75 | <0.001 |
| GATA4, mRNA (AU) | 0.63 | 0.004 | 0.49 | 0.06 |
| TGF-β1, mRNA (AU) | 0.61 | 0.001 | 0.13 | 0.63 |
| MMP9, mRNA (AU) | −0.08 | 0.71 | 0.00 | 0.99 |
| TIMP1, mRNA (AU) | −0.04 | 0.84 | 0.17 | 0.54 |
| NGAL, mRNA (AU) | −0.59 | 0.002 | 0.16 | 0.54 |
| Col1A1, mRNA (AU) | 0.31 | 0.14 | −0.23 | 0.41 |
| Col1A2, mRNA (AU) | 0.20 | 0.33 | −0.33 | 0.23 |
| Col3A1, mRNA (AU) | 0.09 | 0.65 | −0.24 | 0.41 |
| Water soluble collagen (μg/mg wet tissue) | −0.41 | 0.06 | 0.06 | 0.85 |
| Total recoverable collagen (μg/mg wet tissue) | −0.16 | 0.44 | −0.19 | 0.53 |
| Total gelatinolytic activity (AU) | −0.49 | 0.02 | −0.32 | 0.31 |
| Cross-sectional cardiomyocyte diameter (μm) | −0.36 | 0.09 | 0.53 | 0.08 |
LVEF left ventricle ejection fraction, LVEDV left ventricle end-diastolic volume, LVEDV, relative increase (LVEDV in end-point/LVEDV 1 month before euthanasia)*100 %, LA/Ao left atrial/aorta ratio, RWTd relative wall thickness at end diastole (2 × LVPWd/LVEDD, LVPWd end-diastolic thickness of left ventricle posterior wall, LVEDD left ventrical end-diastolic diameter), Em/Am the ratio of an early and late diastolic velocity, BNP B-type natriuretic peptide, GATA4 GATA binding protein 4, TGF-β1 transforming growth factor β1, MMP9 matrix metalloproteinase type 9, NGAL neutrophil gelatinase-associated lipocalin, TIMP1 tissue inhibitor of metalloproteinases type 1, Col1A1 collagen, type I, alpha 1, Col1A2 collagen type I, alpha 2, Col3A1 collagen type III, alpha 1
Sex-related differences in selected echocardiography parameters and molecular markers related to myocardial remodeling assessed in left ventricle in male and female pigs with and without tachycardia-induced cardiomyopathy (the results of the two-way ANOVA)
| Variables (units) | Sex | HF groups | Interactions (sex and HF groups) |
|---|---|---|---|
| F p | F p | F p | |
| LVEF (%) | 0.85 0.36 | 9.59 < 0.001 | 1.06 0.38 |
| LVEDV (ml) | 6.61 0.02 | 8.04 < 0.001 | 2.51 0.08 |
| LVEDV, relative increase (%) | 0.26 0.61 | 3.83 0.019 | 1.74 0.18 |
| LA/Ao | 0.00 0.95 | 14.79 < 0.001 | 1.71 0.18 |
| RWTd | 0.94 0.34 | 3.59 0.02 | 0.64 0.59 |
| Em/Am | 0.11 0.74 | 0.20 0.89 | 0.25 0.86 |
| BNP, mRNA (AU) | 7.16 0.01 | 3.36 0.03 | 2.07 0.12 |
| GATA4, mRNA (AU) | 5.29 0.03 | 1.22 0.32 | 1.04 0.39 |
| TGF-β1, mRNA (AU) | 3.43 0.07 | 0.88 0.46 | 0.70 0.56 |
| MMP9, mRNA (AU) | 0.06 0.81 | 2.49 0.08 | 1.81 0.16 |
| TIMP1, mRNA (AU) | 0.68 0.42 | 1.59 0.21 | 0.74 0.53 |
| NGAL, mRNA (AU) | 4.65 0.04 | 1.00 0.40 | 1.65 0.20 |
| Col1A1, mRNA (AU) | 3.54 0.07 | 2.67 0.06 | 0.72 0.55 |
| Col1A2, mRNA (AU) | 5.43 0.03 | 2.51 0.08 | 1.42 0.26 |
| Col3A1, mRNA (AU) | 0.22 0.65 | 3.68 0.02 | 0.48 0.70 |
| Water soluble collagen (μg/mg wet tissue) | 5.22 0.03 | 2.59 0.08 | 0.76 0.53 |
| Total recoverable collagen (μg/mg wet tissue) | 0.63 0.43 | 0.78 0.51 | 1.59 0.21 |
| Total gelatinolytic activity (AU) | 15.59 0.001 | 1.02 0.40 | 0.46 0.71 |
| Cross-sectional cardiomyocyte diameter (μm) | 5.84 0.02 | 0.17 0.92 | 1.78 0.34 |
LVEF left ventricle ejection fraction, LVEDV left ventricle end-diastolic volume, LVEDV, relative increase LVEDV in end-point/LVEDV 1 month before euthanasia)*100 %, LA/Ao left atrial/aorta ratio, RWTd relative wall thickness at end diastole (2 × LVPWd/LVEDD, LVPWd end-diastolic thickness of left ventricle posterior wall, LVEDD left ventrical end-diastolic diameter), Em/Am the ratio of an early and late diastolic velocity, BNP B-type natriuretic peptide, GATA4 GATA binding protein 4, TGF-β1 transforming growth factor β1, MMP9 matrix metalloproteinase type 9, NGAL neutrophil gelatinase-associated lipocalin, TIMP1 tissue inhibitor of metalloproteinases type 1, Col1A1 collagen, type I, alpha 1, Col1A2 collagen type I, alpha 2, Col3A1 collagen type III, alpha 1
Fig. 2RNA expression of selected genes related to neurohormonal activation, hypertrophy, and extracellular matrix remodeling. RNA level was determined in left ventricle myocardium in sham-operated pigs (controls) and in right ventricle (RV) paced pigs in subsequent stages of heart failure (mild, moderate, and severe HF), separately in male (black columns) and female animals (white columns). a B-type natriuretic peptide (BNP), b GATA binding protein 4 (GATA4), c transforming growth factor-β1 (TGF-β1), d matrix metalloproteinase type 9 (MMP9), e tissue inhibitor of metalloproteinases type 1 (TIMP1), and f neutrophil gelatinase-associated lipocalin (NGAL). mRNA expression was quantified using real-time RT-PCR and normalized against the product of GAPDH. Values are presented as means ± SEM. *p < 0.05 vs. the control group; p < 0.05 female vs. male pigs (in particular study group)
Fig. 3Extracellular matrix turnover indices in sham-operated pigs and in right ventricle (RV) paced pigs. Collagen mRNA and ECM turnover was evaluated in subsequent stages of heart failure (mild, moderate, and severe HF), separately in male (black columns) and female animals (white columns). a Col1A1—collagen, type I, alpha 1; b Col1A2—collagen type I, alpha 2; c—Col3A1collagen type III, alpha 1. d shows total gelatinolytic activity quantified using an biotin-gelatin assay; e shows water soluble collagen (μg/mg of wet tissue); f shows total recoverable collagen (μg/mg of wet tissue); Values are presented as means ± SEM. *p < 0.05 vs. the control group; p < 0.05 female vs. male pigs (in particular study group)
Fig. 4Histological analysis of cardiomyocyte cross-sectional diameter and collagen content in LV myocardium. a represents cardiomyocyte cross-sectional diameter in subsequent stages of heart failure (mild, moderate, and severe HF), separately in male (black columns) and female animals (white columns). Values are presented as means ± SEM. *p < 0.05 vs. the control group; p < 0.05 female vs. male pigs (in particular study group). Representative photomicrograph of van Gieson-stained sections of LV demonstrating interstitial collagen content and myocyte cross-sectional diameter in controls (sham-operated, b female, c male) and in subsequent stages of heart failure in females (d mild, f moderate, and h severe HF) and in males (e mild, g moderate, and i severe HF). Original magnification ×200; scale bar—100 μm). Note that collagenous network (red) surrounding muscle bundles (yellow) is similar in all shown sections